patients with high clinical complexity should discuss their full history with a qualified provider, whether via Ro or another platform, to ensure safety
As with most GLP-1-related topics at this early stage, insurers have more questions than answers
Similar results were reported by Wang et al., where GLP-1 RA treatment had a notable impact on the abundance of weight-related microbial phylotypes, though no significant change in the Firmicutes/Bacteroidetes ratio was observed (72)
Efficacy and safety over 2 years of exenatide plus dapagliflozin in the DURATION-8 study: a multicenter, double-blind, phase 3, randomized controlled trial
Kushner frames this mostly for people maintaining weight loss without drugs, where the biological pull to regain is relentless
A.ColomboA